Algeria vs Sudan: HIV/AIDS deaths averted by antiretroviral therapy
Algeria
1,007 deaths
in 2024
Sudan
958.82 deaths
in 2024
Algeria rank
73rd
Sudan rank
75th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Algeria
- Sudan
How they compare
Algeria currently reports 1,007 deaths against 958.82 deaths in Sudan, a difference of 48.18 deaths.
That makes Algeria's figure about 1.1 times Sudan's.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Sudan ahead.
Algeria ranks 73rd and Sudan ranks 75th of 157 countries.
Across the 4 decades both report, Algeria averaged higher in 1 and Sudan in 3.
Head to head by decade
| Decade | Algeria | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.15 deaths | 0 deaths | 4.15 deaths | Algeria |
| 2000s | 78.66 deaths | 104.25 deaths | 25.59 deaths | Sudan |
| 2010s | 458.68 deaths | 556.8 deaths | 98.12 deaths | Sudan |
| 2020s | 900.71 deaths | 1,050 deaths | 149.52 deaths | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Algeria or Sudan?
- Algeria, at 1,007 deaths against 958.82 deaths in Sudan as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Algeria and Sudan?
- 48.18 deaths, with Algeria ahead.
- How many years of comparable data are there for Algeria and Sudan?
- 35 years are reported by both, from 1990 to 2024.
- How do Algeria and Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Algeria ranks 73rd and Sudan ranks 75th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.